Tarannum Lateef
Research Subjects
Research Interests
Tarannum Lateef has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Ananya Swaminathan1 shared publication
- Arno Klein
Child Mind Institute
1 shared publication - Camille Leroux
Sorbonne Université, GRC 01, GREEN Groupe de Recherche Clinique en Neuro‐Urologie, AP‐HP, Hôpital Tenon Paris France
1 shared publication - Céline Vetter
Department of Integrative Physiology University of Colorado Boulder Boulder Colorado USA
1 shared publication - David Kepplinger
Department of Statistics, George Mason University, Fairfax, USA
1 shared publication - Debangan Dey
Genetic Epidemiology Research Branch, Intramural Research Program, National Institute of Mental Health
1 shared publication
Latest Publications
- Open Access
- 11 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Real-time Ecological Assessment of the Context of mental and physical Health (REACH): An open-source tool on the Curious platform (Preprint)
UNSTRUCTURED Ecological Momentary Assessment (EMA) is widely used in mental health research to capture internal states and experiences as they occur in real-world settings. Despite its widespread use, the lack of standardization in EMA content, study design, analytical approaches and data collection platforms has hindered comparability across studies and limited the progress in understanding mental health disorders. This paper describes our development of standardized, open-source tools for collecting EMA with the Real-time Ecological Assessment of the Context of mental and physical Health (REACH) app for the Rhythms and Blues Study protocol at the National Institutes of Health Clinical Center, a study that characterizes both the lifetime and dynamic profiles of physical and mental health across the lifespan with modules for procedures, sleep, context, media use, affect, negative thoughts, events, physical activity, diet, substance use, pain, headache, physical health and menstrual cycle. The REACH applet has been integrated into Curious, a secure, open- source, configurable, and scalable (formerly Mindlogger) platform through a collaborative effort with the Child Mind Institute in New York. There are four versions of EMA content in REACH: a full and short version for individuals 12 or older, and a full and short version for children ages 6 through 11. Here, we describe the content, materials, and methods of REACH shared under a Creative Commons license to promote access and harmonization of these tools in global settings across the life span particularly in the mental health field.
- 11 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessReal-time Ecological Assessment of the Context of mental and physical Health (REACH): An open-source tool on the Curious platform (Preprint)
UNSTRUCTURED Ecological Momentary Assessment (EMA) is widely used in mental health research to capture internal states and experiences as they occur in real-world settings. Despite its widespread use, the lack of standardization in EMA content, study design, analytical approaches and data collection platforms has hindered comparability across studies and limited the progress in understanding mental health disorders. This paper describes our development of standardized, open-source tools for collecting EMA with the Real-time Ecological Assessment of the Context of mental and physical Health (REACH) app for the Rhythms and Blues Study protocol at the National Institutes of Health Clinical Center, a study that characterizes both the lifetime and dynamic profiles of physical and mental health across the lifespan with modules for procedures, sleep, context, media use, affect, negative thoughts, events, physical activity, diet, substance use, pain, headache, physical health and menstrual cycle. The REACH applet has been integrated into Curious, a secure, open- source, configurable, and scalable (formerly Mindlogger) platform through a collaborative effort with the Child Mind Institute in New York. There are four versions of EMA content in REACH: a full and short version for individuals 12 or older, and a full and short version for children ages 6 through 11. Here, we describe the content, materials, and methods of REACH shared under a Creative Commons license to promote access and harmonization of these tools in global settings across the life span particularly in the mental health field.
- Open Access
- 21 February 2025
- Published by Science Publishing Group in Clinical Neurology and Neuroscience
- Vol. 9 (1) , 13-19
Clinical Factors Associated with Opioid Use in Abortive Headache Treatment Among Adolescents in the Emergency Department: Who Gets Them and Why
Background: Routine use of opioids for headache can lead to worsening symptoms and may contribute to dependence. This study’s main objective was to determine the prevalence and clinical factors associated with opioids used as abortive therapy, for adolescents presenting with headache, in a pediatric emergency room. Methods: We reviewed electronic medical records of youth aged 11 through 21 years presenting to a large suburban pediatric emergency department between January 2014 and December 2020, who were prescribed opioids for headache. Charts were analyzed for demographics, medications prescribed, clinical characteristics, and final diagnoses. Results: 204 youths were seen for headache and received an opioid abortive medication for it. Among those 70 received it for a procedure such as lumbar puncture. Of the remaining 134 patients – 126 received morphine, 28 – hydromorphone/hydrocodone, 26 – oxycodone, tramadol – 9, meperidine – 6, codeine/fiorcet/fentanyl – 8, and methadone – 1. Over half the patients (n=118, 58%) were female, 24% (n=49) had a prior headache history, 20% (n=41) seen a neurologist, and 30% (n=62) had a past psychiatric history. In terms of headache specific factors, only 15% (n=31) were on daily headache prophylaxis. Notably 46% (n=93) had a history of prior opioid use and only 9% (n=18) had used an ergot medication. Conclusion: Youth receiving opioids for headache treatment were more likely to be female, had significant mental health comorbidity, and without access to specialty neurology care. Our findings may help identify youth headache sufferers at risk for opioid use and highlight the need for early identification and referral to a neurologist.
- 21 February 2025
- Published by Science Publishing Group in Clinical Neurology and Neuroscience
- Vol. 9 (1) , 13-19
Open AccessClinical Factors Associated with Opioid Use in Abortive Headache Treatment Among Adolescents in the Emergency Department: Who Gets Them and Why
Background: Routine use of opioids for headache can lead to worsening symptoms and may contribute to dependence. This study’s main objective was to determine the prevalence and clinical factors associated with opioids used as abortive therapy, for adolescents presenting with headache, in a pediatric emergency room. Methods: We reviewed electronic medical records of youth aged 11 through 21 years presenting to a large suburban pediatric emergency department between January 2014 and December 2020, who were prescribed opioids for headache. Charts were analyzed for demographics, medications prescribed, clinical characteristics, and final diagnoses. Results: 204 youths were seen for headache and received an opioid abortive medication for it. Among those 70 received it for a procedure such as lumbar puncture. Of the remaining 134 patients – 126 received morphine, 28 – hydromorphone/hydrocodone, 26 – oxycodone, tramadol – 9, meperidine – 6, codeine/fiorcet/fentanyl – 8, and methadone – 1. Over half the patients (n=118, 58%) were female, 24% (n=49) had a prior headache history, 20% (n=41) seen a neurologist, and 30% (n=62) had a past psychiatric history. In terms of headache specific factors, only 15% (n=31) were on daily headache prophylaxis. Notably 46% (n=93) had a history of prior opioid use and only 9% (n=18) had used an ergot medication. Conclusion: Youth receiving opioids for headache treatment were more likely to be female, had significant mental health comorbidity, and without access to specialty neurology care. Our findings may help identify youth headache sufferers at risk for opioid use and highlight the need for early identification and referral to a neurologist.